While PGI2 inhibited agonist-induced increases in platelet CD62P, integrin αIIbβ3 and PS, the inhibitory effect of PGI2 was diminished in those with type 1 diabetes. The gene discussed is SELP; the disease is type 1 diabetes mellitus.